A 7-Chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine 4-oxide hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of 7-Chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine 4-oxide hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of 7-Chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine 4-oxide hydrochloride DMFs exist exist since differing nations have different regulations, such as 7-Chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine 4-oxide hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 7-Chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine 4-oxide hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. 7-Chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine 4-oxide hydrochloride USDMF includes data on 7-Chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine 4-oxide hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 7-Chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine 4-oxide hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 7-Chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine 4-oxide hydrochloride suppliers with USDMF on PharmaCompass.